Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Phase-II Randomized Trial of Three Liposomal Amphotericin B Regimens as Induction Therapy for Disseminated Histoplasmosis in AIDS Patients

NCT04059770 is registered in ClinicalTrials.gov with Alessandro Pasqualotto as lead sponsor.

NCT NCT04059770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04059770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Phase-II Randomized Trial of Three Liposomal Amphotericin B Regimens as Induction Therapy for Disseminated Histoplasmosis in AIDS Patients
Lead sponsor
Alessandro Pasqualotto
Phase
Phase 2
Overall status
Completed
Start date
February 14, 2020
Completion date
March 30, 2022
Enrollment
118 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aids, histoplasmosis